Serveur d'exploration sur le cobalt au Maghreb

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type

Identifieur interne : 000455 ( France/Analysis ); précédent : 000454; suivant : 000456

Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type

Auteurs : N. Azli [Algérie] ; J. P Armand [France] ; M. Rahal [Algérie] ; P. Wibault [France] ; H. Boussen [Tunisie] ; F. Eschwege [France] ; G. Schwaab [France] ; J. Gasmi [France] ; M. Bachouchi [France] ; E. Cvitkovic [France]

Source :

RBID : ISTEX:3CF1F5540FA63EEE0C128E93727A934BCDF2BD31

Abstract

More than 80% of undifferentiated carcinoma nasopharyngeal type patients with N3 disease (AJC-UICC 1987) will die with or from distant metastases within 3 years after the first symptom. From February 1986 to November 1987 30 consecutive patients with very advanced local disease were entered in a programme with chemotherapy-radiotherapy (CT-RT) alternation after a thorough work-up to eliminate the possibility of distant metastases. Protocol: two cycles of cisplatin 100 mg/m2 day 1, bleomycin 15 mg intravenously day 1 and 16 mg/m2 per day by continuous infusion days 1–5; 5-fluorouracil (5-FU) 650 mg/m2 per day by continuous infusion days 1–5 4 weeks apart. This was followed by two series of high-energy radiotherapy, 35 Gy/3.5 weeks, with a third chemotherapy cycle in between. 27 men and 3 women were treated, the median age was 37 years (range 17–71) and the mean WHO performance status was 1 (range 0–3). TNM classification: 15 T4, 9 T3, 6 T2, 28 N3 and 2 N2c. 18 patients had nodes larger than 8 cm and 24 had bulky bilateral cervical nodes. Toxicity for this protocol was moderate, nausea and vomiting being the main side-effects. Results after two CT cycles were 3 complete responses (CR; 10%), 22 partial responses (PR; 73%), 2 disease stabilisations, 2 progressions, and 1 patient inevaluable. Of the 30 patients, 27 patients completed the CT-RT protocol, 2 patients died before radiotherapy and 1 refused treatment after 2 days on protocol. 25 patients were in CR 3 months after the end of radiotherapy. As of August 1991, with a median follow-up of 55 months (range 43–63), there are 17 patients alive, 2 of them with active disease and 15 are NED (2 after salvage therapy).

Url:
DOI: 10.1016/0959-8049(92)90005-M


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:3CF1F5540FA63EEE0C128E93727A934BCDF2BD31

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type</title>
<author>
<name sortKey="Azli, N" sort="Azli, N" uniqKey="Azli N" first="N" last="Azli">N. Azli</name>
</author>
<author>
<name sortKey="Armand, J P" sort="Armand, J P" uniqKey="Armand J" first="J. P" last="Armand">J. P Armand</name>
</author>
<author>
<name sortKey="Rahal, M" sort="Rahal, M" uniqKey="Rahal M" first="M" last="Rahal">M. Rahal</name>
</author>
<author>
<name sortKey="Wibault, P" sort="Wibault, P" uniqKey="Wibault P" first="P" last="Wibault">P. Wibault</name>
</author>
<author>
<name sortKey="Boussen, H" sort="Boussen, H" uniqKey="Boussen H" first="H" last="Boussen">H. Boussen</name>
</author>
<author>
<name sortKey="Eschwege, F" sort="Eschwege, F" uniqKey="Eschwege F" first="F" last="Eschwege">F. Eschwege</name>
</author>
<author>
<name sortKey="Schwaab, G" sort="Schwaab, G" uniqKey="Schwaab G" first="G" last="Schwaab">G. Schwaab</name>
</author>
<author>
<name sortKey="Gasmi, J" sort="Gasmi, J" uniqKey="Gasmi J" first="J" last="Gasmi">J. Gasmi</name>
</author>
<author>
<name sortKey="Bachouchi, M" sort="Bachouchi, M" uniqKey="Bachouchi M" first="M" last="Bachouchi">M. Bachouchi</name>
</author>
<author>
<name sortKey="Cvitkovic, E" sort="Cvitkovic, E" uniqKey="Cvitkovic E" first="E" last="Cvitkovic">E. Cvitkovic</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:3CF1F5540FA63EEE0C128E93727A934BCDF2BD31</idno>
<date when="1992" year="1992">1992</date>
<idno type="doi">10.1016/0959-8049(92)90005-M</idno>
<idno type="url">https://api.istex.fr/document/3CF1F5540FA63EEE0C128E93727A934BCDF2BD31/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000599</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000599</idno>
<idno type="wicri:Area/Istex/Curation">000293</idno>
<idno type="wicri:Area/Istex/Checkpoint">000B45</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000B45</idno>
<idno type="wicri:doubleKey">0959-8049:1992:Azli N:alternating:chemo:radiotherapy</idno>
<idno type="wicri:Area/Main/Merge">001387</idno>
<idno type="wicri:Area/Main/Curation">001335</idno>
<idno type="wicri:Area/Main/Exploration">001335</idno>
<idno type="wicri:Area/France/Extraction">000455</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type</title>
<author>
<name sortKey="Azli, N" sort="Azli, N" uniqKey="Azli N" first="N" last="Azli">N. Azli</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Algérie</country>
<wicri:regionArea>C.A.C. Benbadis, Constantine</wicri:regionArea>
<wicri:noRegion>Constantine</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Armand, J P" sort="Armand, J P" uniqKey="Armand J" first="J. P" last="Armand">J. P Armand</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Gustave-Roussy, Unite La Grange Villejuif</wicri:regionArea>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rahal, M" sort="Rahal, M" uniqKey="Rahal M" first="M" last="Rahal">M. Rahal</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Algérie</country>
<wicri:regionArea>C.A.C. Benbadis, Constantine</wicri:regionArea>
<wicri:noRegion>Constantine</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Wibault, P" sort="Wibault, P" uniqKey="Wibault P" first="P" last="Wibault">P. Wibault</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Gustave-Roussy, Unite La Grange Villejuif</wicri:regionArea>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Boussen, H" sort="Boussen, H" uniqKey="Boussen H" first="H" last="Boussen">H. Boussen</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Tunisie</country>
<wicri:regionArea>Institut Salah Azaiz, Tunis</wicri:regionArea>
<placeName>
<settlement type="city">Tunis</settlement>
<region nuts="2">Gouvernorat de Tunis</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Eschwege, F" sort="Eschwege, F" uniqKey="Eschwege F" first="F" last="Eschwege">F. Eschwege</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Gustave-Roussy, Unite La Grange Villejuif</wicri:regionArea>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Schwaab, G" sort="Schwaab, G" uniqKey="Schwaab G" first="G" last="Schwaab">G. Schwaab</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Gustave-Roussy, Unite La Grange Villejuif</wicri:regionArea>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gasmi, J" sort="Gasmi, J" uniqKey="Gasmi J" first="J" last="Gasmi">J. Gasmi</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Gustave-Roussy, Unite La Grange Villejuif</wicri:regionArea>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Bachouchi, M" sort="Bachouchi, M" uniqKey="Bachouchi M" first="M" last="Bachouchi">M. Bachouchi</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Gustave-Roussy, Unite La Grange Villejuif</wicri:regionArea>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Cvitkovic, E" sort="Cvitkovic, E" uniqKey="Cvitkovic E" first="E" last="Cvitkovic">E. Cvitkovic</name>
<affiliation></affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Gustave-Roussy, Unite La Grange Villejuif</wicri:regionArea>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">European Journal of Cancer</title>
<title level="j" type="abbrev">EJC</title>
<idno type="ISSN">0959-8049</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1992">1992</date>
<biblScope unit="volume">28</biblScope>
<biblScope unit="issue">11</biblScope>
<biblScope unit="page" from="1792">1792</biblScope>
<biblScope unit="page" to="1797">1797</biblScope>
</imprint>
<idno type="ISSN">0959-8049</idno>
</series>
<idno type="istex">3CF1F5540FA63EEE0C128E93727A934BCDF2BD31</idno>
<idno type="DOI">10.1016/0959-8049(92)90005-M</idno>
<idno type="PII">0959-8049(92)90005-M</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0959-8049</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">More than 80% of undifferentiated carcinoma nasopharyngeal type patients with N3 disease (AJC-UICC 1987) will die with or from distant metastases within 3 years after the first symptom. From February 1986 to November 1987 30 consecutive patients with very advanced local disease were entered in a programme with chemotherapy-radiotherapy (CT-RT) alternation after a thorough work-up to eliminate the possibility of distant metastases. Protocol: two cycles of cisplatin 100 mg/m2 day 1, bleomycin 15 mg intravenously day 1 and 16 mg/m2 per day by continuous infusion days 1–5; 5-fluorouracil (5-FU) 650 mg/m2 per day by continuous infusion days 1–5 4 weeks apart. This was followed by two series of high-energy radiotherapy, 35 Gy/3.5 weeks, with a third chemotherapy cycle in between. 27 men and 3 women were treated, the median age was 37 years (range 17–71) and the mean WHO performance status was 1 (range 0–3). TNM classification: 15 T4, 9 T3, 6 T2, 28 N3 and 2 N2c. 18 patients had nodes larger than 8 cm and 24 had bulky bilateral cervical nodes. Toxicity for this protocol was moderate, nausea and vomiting being the main side-effects. Results after two CT cycles were 3 complete responses (CR; 10%), 22 partial responses (PR; 73%), 2 disease stabilisations, 2 progressions, and 1 patient inevaluable. Of the 30 patients, 27 patients completed the CT-RT protocol, 2 patients died before radiotherapy and 1 refused treatment after 2 days on protocol. 25 patients were in CR 3 months after the end of radiotherapy. As of August 1991, with a median follow-up of 55 months (range 43–63), there are 17 patients alive, 2 of them with active disease and 15 are NED (2 after salvage therapy).</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Algérie</li>
<li>France</li>
<li>Tunisie</li>
</country>
<region>
<li>Gouvernorat de Tunis</li>
</region>
<settlement>
<li>Tunis</li>
</settlement>
</list>
<tree>
<country name="Algérie">
<noRegion>
<name sortKey="Azli, N" sort="Azli, N" uniqKey="Azli N" first="N" last="Azli">N. Azli</name>
</noRegion>
<name sortKey="Rahal, M" sort="Rahal, M" uniqKey="Rahal M" first="M" last="Rahal">M. Rahal</name>
</country>
<country name="France">
<noRegion>
<name sortKey="Armand, J P" sort="Armand, J P" uniqKey="Armand J" first="J. P" last="Armand">J. P Armand</name>
</noRegion>
<name sortKey="Bachouchi, M" sort="Bachouchi, M" uniqKey="Bachouchi M" first="M" last="Bachouchi">M. Bachouchi</name>
<name sortKey="Cvitkovic, E" sort="Cvitkovic, E" uniqKey="Cvitkovic E" first="E" last="Cvitkovic">E. Cvitkovic</name>
<name sortKey="Eschwege, F" sort="Eschwege, F" uniqKey="Eschwege F" first="F" last="Eschwege">F. Eschwege</name>
<name sortKey="Gasmi, J" sort="Gasmi, J" uniqKey="Gasmi J" first="J" last="Gasmi">J. Gasmi</name>
<name sortKey="Schwaab, G" sort="Schwaab, G" uniqKey="Schwaab G" first="G" last="Schwaab">G. Schwaab</name>
<name sortKey="Wibault, P" sort="Wibault, P" uniqKey="Wibault P" first="P" last="Wibault">P. Wibault</name>
</country>
<country name="Tunisie">
<region name="Gouvernorat de Tunis">
<name sortKey="Boussen, H" sort="Boussen, H" uniqKey="Boussen H" first="H" last="Boussen">H. Boussen</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/CobaltMaghrebV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000455 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000455 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Terre
   |area=    CobaltMaghrebV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     ISTEX:3CF1F5540FA63EEE0C128E93727A934BCDF2BD31
   |texte=   Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type
}}

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Tue Nov 14 12:56:51 2017. Site generation: Mon Feb 12 07:59:49 2024